Author： Tepper S.J.
Publisher： Adis International
ISSN： 1172-7047
Source： CNS Drugs, Vol.12, Iss.5, 1999-11, pp. : 403-417
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Vries P.D. Villalón C.M. Saxena P.R.
Expert Opinion on Emerging Drugs, Vol. 4, Iss. 1, 1999-01 ,pp. :
Access to resources
Recommend
Tolerability of the Triptans: Clinical Implications
By Nappi G.
Drug Safety, Vol. 26, Iss. 2, 2003-01 ,pp. :
The Use of Triptans for Pediatric Migraines
Pediatric Drugs, Vol. 12, Iss. 6, 2010-12 ,pp. :
Triptans for the Management of Migraine
By Johnston Mollie M. Rapoport Alan M.
Drugs, Vol. 70, Iss. 12, 2010-08 ,pp. :
Safety profile of the triptans
By Tepper Stewart J Millson David
Expert Opinion on Drug Safety, Vol. 2, Iss. 2, 2003-03 ,pp. :